Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

38.15
Delayed Data
As of Dec 08
 0.00 / 0.00%
Today’s Change
21.60
Today|||52-Week Range
50.05
+51.09%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close38.15
Today’s open37.80
Day’s range37.34 - 38.30
Volume227,408
Average volume (3 months)636,643
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-38.47%
Earnings growth (next 5 years)+27.00%
Revenue growth (last year)+48.87%
P/E ratio34.7
Price/Sales6.07
Price/Book9.94

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...0.000.00%
HZNPHorizon Pharma PLC0.000.00%
FOLDAmicus Therapeutics ...0.000.00%
AXONAxovant Sciences Ltd0.000.00%
Data as of 4:00pm ET, 12/08/2017

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)$0.28
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts